Home

Remus Pharmaceuticals Ltd EPS

Image

Remus Pharmaceuticals Ltd

NSE: RemusPharma.

EPS

₹ 34.52

Last updated on: Feb 21, 2025

Key Highlights

  • The Earning per Share of Remus Pharmaceuticals Ltd is ₹ 34.52 as of 21 Feb 25 .

Historical P/B Ratio of Remus Pharmaceuticals Ltd

No data available

Company Fundamentals for Remus Pharmaceuticals Ltd

Market Price of Remus Pharmaceuticals Ltd

1M

1Y

3Y

5Y

Monitoring Remus Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
21 Feb 20251977.35
20 Feb 20251927.85
19 Feb 20251927.1
18 Feb 20251865.4
17 Feb 20252031.45
14 Feb 20251926.65
13 Feb 20252002
12 Feb 20251972.7
11 Feb 20251935.1
10 Feb 20251996.5

SWOT Analysis Of Remus Pharmaceuticals Ltd

Strength

4

che

Weakness

3

che

Opportunity

0

che

Threats

0

che

BlinkX Score for Remus Pharmaceuticals Ltd

Asset Value vs Market Value of Remus Pharmaceuticals Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

Historical Market Cap of Remus Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Revenue of Remus Pharmaceuticals Ltd

No data available

* All values are in crore

Historical EBITDA of Remus Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Net Profit of Remus Pharmaceuticals Ltd

No data available

* All values are in crore

Dividend Payout Over Time

No data available

Remus Pharmaceuticals Ltd News Hub

Remus Pharmaceuticals to convene AGM

Remus Pharmaceuticals announced that the 9th Annual General Meeting (AGM) of the company will be hel

Read more

31 Aug 24

Board of Remus Pharmaceuticals recommends interim dividend

Remus Pharmaceuticals announced that the Board of Directors of the Company at its meeting held on 9

Read more

09 Nov 24

Remus Pharmaceuticals to convene board meeting

Remus Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 9 November 202

Read more

07 Nov 24

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for EPS of Remus Pharmaceuticals Ltd

What is the EPS of Remus Pharmaceuticals Ltd stock?

The Earnings Per Share (EPS) of Remus Pharmaceuticals Ltd is 0.0. An EPS is the amount of net income attributed to each share of a common stock.

How is Remus Pharmaceuticals Ltd EPS calculated?

The EPS of Remus Pharmaceuticals Ltd is calculated by dividing the net income by the number of outstanding shares. The formula is EPS = (Net Income - Dividends on Preferred Stock) / Average Outstanding Shares.

How often does Remus Pharmaceuticals Ltd report its EPS?

Remus Pharmaceuticals Ltd typically reports its EPS quarterly and annually, in conjunction with its financial statements and earnings reports.

What factors can influence Remus Pharmaceuticals Ltd EPS?

Factors that influence the EPS of Remus Pharmaceuticals Ltd include revenue changes, cost fluctuations, operational efficiency, tax rates, and one-time gains or losses.

Can Remus Pharmaceuticals Ltd EPS growth indicate future performance?

Yes, consistent growth in Remus Pharmaceuticals Ltd EPS can suggest strong financial health and effective management, potentially indicating positive future performance.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions